These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
783 related articles for article (PubMed ID: 9007714)
1. Identification of cyclin A as a molecular target of antinuclear antibodies (ANA) in hepatic and non-hepatic autoimmune diseases. Strassburg CP; Alex B; Zindy F; Gerken G; Lüttig B; Meyer zum Büschenfelde KH; Bréchot C; Manns MP J Hepatol; 1996 Dec; 25(6):859-66. PubMed ID: 9007714 [TBL] [Abstract][Full Text] [Related]
2. Investigation and analysis of HEp 2 indirect immunofluorescence titers and patterns in various liver diseases. Wei Q; Jiang Y; Xie J; Yang M; Zhang Y; Wu Z; Chen S; Liao Z; Lin Z; Gu J Clin Rheumatol; 2020 Aug; 39(8):2425-2432. PubMed ID: 32103375 [TBL] [Abstract][Full Text] [Related]
3. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity. Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101 [TBL] [Abstract][Full Text] [Related]
4. [Investigation of the Contribution of Autoantibodies to Clinical Diagnosis in Liver Pathologies and the Identification of Accompanying Autoimmune Diseases]. Duran A; Çetin Duran A; Taşkıran İ Mikrobiyol Bul; 2022 Jan; 56(1):81-94. PubMed ID: 35088962 [TBL] [Abstract][Full Text] [Related]
5. Anti-liver cytosolic antigen type 1 (LC1) antibodies in childhood autoimmune liver disease. Han S; Tredger M; Gregorio GV; Mieli-Vergani G; Vergani D Hepatology; 1995 Jan; 21(1):58-62. PubMed ID: 7806169 [TBL] [Abstract][Full Text] [Related]
6. Do autoantibodies predict autoimmune liver disease in primary Sjögren's syndrome? Data of 180 patients upon a 5 year follow-up. Csepregi A; Szodoray P; Zeher M Scand J Immunol; 2002 Dec; 56(6):623-9. PubMed ID: 12472675 [TBL] [Abstract][Full Text] [Related]
7. [Detection of anti-nuclear antibodies in liver diseases by indirect immunofluorescence method and enzyme-linked immunosorbent assay]. Koizumi H; Onozuka Y; Shibata M; Sano K; Oosima Y; Miyachi K; Ueno Y Rinsho Byori; 1999 Aug; 47(8):744-8. PubMed ID: 10511806 [TBL] [Abstract][Full Text] [Related]
8. Identification of specific antinuclear antibodies in dogs using a line immunoassay and enzyme-linked immunosorbent assay. Bremer HD; Lattwein E; Renneker S; Lilliehöök I; Rönnelid J; Hansson-Hamlin H Vet Immunol Immunopathol; 2015 Dec; 168(3-4):233-41. PubMed ID: 26547884 [TBL] [Abstract][Full Text] [Related]
9. Clinical significance of different antinuclear antibodies patterns in the course of primary biliary cirrhosis. Remmel T; Piirsoo A; Koiveer A; Remmel H; Uibo R; Salupere V Hepatogastroenterology; 1996; 43(11):1135-40. PubMed ID: 8908541 [TBL] [Abstract][Full Text] [Related]
10. Specificity of antinuclear antibodies in primary biliary cirrhosis. Chou MJ; Lee SL; Chen TY; Tsay GJ Ann Rheum Dis; 1995 Feb; 54(2):148-51. PubMed ID: 7702406 [TBL] [Abstract][Full Text] [Related]
11. Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma. Imai H; Nakano Y; Kiyosawa K; Tan EM Cancer; 1993 Jan; 71(1):26-35. PubMed ID: 8380118 [TBL] [Abstract][Full Text] [Related]
13. Autoantibody profiles in canine ANA-positive sera investigated by immunoblot and ELISA. Welin Henriksson E; Hansson H; Karlsson-Parra A; Pettersson I Vet Immunol Immunopathol; 1998 Feb; 61(2-4):157-70. PubMed ID: 9613431 [TBL] [Abstract][Full Text] [Related]
14. [Autoimmune hepatitis and overlap syndrome: diagnosis]. Berg PA; Klein R Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264 [TBL] [Abstract][Full Text] [Related]
15. The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis. Luettig B; Boeker KH; Schoessler W; Will H; Loges S; Schmidt E; Worman HJ; Gershwin ME; Manns MP J Hepatol; 1998 May; 28(5):824-8. PubMed ID: 9625318 [TBL] [Abstract][Full Text] [Related]
16. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Cassani F; Cataleta M; Valentini P; Muratori P; Giostra F; Francesconi R; Muratori L; Lenzi M; Bianchi G; Zauli D; Bianchi FB Hepatology; 1997 Sep; 26(3):561-6. PubMed ID: 9303483 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China. Yang Z; Ren Y; Liu D; Lin F; Liang Y APMIS; 2016 Sep; 124(9):805-11. PubMed ID: 27328803 [TBL] [Abstract][Full Text] [Related]
18. Immunoblot assay for detection of autoantibodies in autoimmune disease. Capín NG; Rodriguez MR; Lavalle CM; Ortiz-Ortiz L J Clin Lab Anal; 1992; 6(5):319-23. PubMed ID: 1403353 [TBL] [Abstract][Full Text] [Related]
19. Performance of indirect immunofluorescence test and immunoblot tests in the evaluation of antinuclear and antimitochondrial antibodies. Öztürk Ö; Dos Santos Duarte SD; Balaban HY; Şimşek H; Şener B Turk J Med Sci; 2022 Apr; 52(5):1697-1703. PubMed ID: 36422475 [TBL] [Abstract][Full Text] [Related]